Fresh Recalls

Zydus Pharmaceuticals (USA) recalls

3 recent recalls on record for Zydus Pharmaceuticals (USA) in connected official government data as of September 7, 2026 at 6:00 AM UTC.

Models with recalls

Erythromycin Tablets (2)Mirabegron Extended-Release Tablets (1)

All Zydus Pharmaceuticals (USA) recalls

FDA Class II · Drug · August 12, 2026

Mirabegron Extended-Release Tablets recall — Zydus Pharmaceuticals (USA) Inc

CGMP: Due to Out of Specification (OOS) result for N-Nitroso Mirabegron impurity.

Official ID D-0745-2026 · Official record ↗

FDA Class II · Drug · May 27, 2026

Erythromycin Tablets recall — Zydus Pharmaceuticals (USA) Inc

CGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit

Official ID D-0545-2026 · Official record ↗

FDA Class II · Drug · May 27, 2026

Erythromycin Tablets recall — Zydus Pharmaceuticals (USA) Inc

CGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit

Official ID D-0544-2026 · Official record ↗

Verify with the official sources:

Found something wrong or missing? Report a data error.

Compiled from official public-domain government data. Last checked September 7, 2026 at 6:00 AM UTC.